Host biomarkers of clinical relevance in tuberculosis: review of gene and protein expression studies

References

• Aabye MG, Ravn P, PrayGod G, Jeremiah K, Mugomela A, Jepsen M, Faurholt D, Range N, Friis H, Changalucha J, Andersen AB. (2009). The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS ONE 4:e4220.
   Google Scholar
• Agranoff D, Fernandez-Reyes D, Papadopoulos MC, Rojas SA, Herbster M, Loosemore A, Tarelli E, Sheldon J, Schwenk A, Pollok R, Rayner CF, Krishna S. (2006). Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 368:1012–1021.
   PubMed Web of Science ®Google Scholar
• Azzurri A, Sow OY, Amedei A, Bah B, Diallo S, Peri G, Benagiano M, D’Elios MM, Mantovani A, Del Prete G. (2005). IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect 7:1–8.
   PubMed Web of Science ®Google Scholar
• Babu S, Bhat SQ, Kumar NP, Kumaraswami V, Nutman TB. (2010). Regulatory T cells modulate Th17 responses in patients with positive tuberculin skin test results. J Infect Dis 201:20–31.
   PubMedGoogle Scholar
• Biselli R, Mariotti S, Sargentini V, Sauzullo I, Lastilla M, Mengoni F, Vanini V, Girardi E, Goletti D, D’ Amelio R, Nisini R. (2010). Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls. Clin Microbiol Infect 16:1282–1284.
   Google Scholar
• Burl S, Hill PC, Jeffries DJ, Holland MJ, Fox A, Lugos MD, Adegbola RA, Rook GA, Zumla A, McAdam KP, Brookes RH. (2007). FOXP3 gene expression in a tuberculosis case contact study. Clin Exp Immunol 149:117–122.
   Google Scholar
• Chegou NN, Black GF, Kidd M, van Helden PD, Walzl G. (2009). Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm Med 9:21.
   PubMedGoogle Scholar
• Chen X, Zhang M, Liao M, Graner MW, Wu C, Yang Q, Liu H, Zhou B. (2010). Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells. Am J Respir Crit Care Med 181:734–742.
   Google Scholar
• Delgado JC, Tsai EY, Thim S, Baena A, Boussiotis VA, Reynes JM, Sath S, Grosjean P, Yunis EJ, Goldfeld AE. (2002). Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia. Proc Natl Acad Sci USA 99:7576–7581.
   Google Scholar
• Demissie A, Abebe M, Aseffa A, Rook G, Fletcher H, Zumla A, Weldingh K, Brock I, Andersen P, Doherty TM; VACSEL Study Group. (2004). Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2. J Immunol 172:6938–6943.
   PubMed Web of Science ®Google Scholar
• Deveci F, Akbulut HH, Turgut T, Muz MH. (2005). Changes in serum cytokine levels in active tuberculosis with treatment. Mediators Inflamm 2005:256–262.
   PubMedGoogle Scholar
• Dheda K, Chang JS, Breen RA, Kim LU, Haddock JA, Huggett JF, Johnson MA, Rook GA, Zumla A. (2005). In vivo and in vitro studies of a novel cytokine, interleukin 4delta2, in pulmonary tuberculosis. Am J Respir Crit Care Med 172:501–508.
   PubMed Web of Science ®Google Scholar
• Djoba Siawaya JF, Beyers N, van Helden P, Walzl G. (2009). Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis. Clin Exp Immunol 156:69–77.
   PubMed Web of Science ®Google Scholar
• Djoba Siawaya JF, Chegou NN, van den Heuvel MM, Diacon AH, Beyers N, van Helden P, Walzl G. (2009). Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis. Cytokine 47:132–136.
   PubMedGoogle Scholar
• Doherty TM, Wallis RS, Zumla A. (2009). Biomarkers of disease activity, cure, and relapse in tuberculosis. Clin Chest Med 30:783–96, x.
   Google Scholar
• Fletcher HA, Owiafe P, Jeffries D, Hill P, Rook GA, Zumla A, Doherty TM, Brookes RH; VACSEL Study Group. (2004). Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation. Immunology 112:669–673.
   Google Scholar
• Frahm M, Goswami N, Owzar K, Hecker E, Mosher A, Cadogan E, Ferrari G, Nahid P,Stout J. (2010). Multi-cytokine Profiles After Tuberculosis Antigen Stimulation: A Search For New Biomarkers For Latent And Active Tuberculosis. Am J Respir Crit Care Med 181: A2261.
   Google Scholar
• Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A. (2006). Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 173:803–810.
   PubMedGoogle Scholar
• Handzel ZT, Barak V, Altman Y, Bibi H, Lidgi M, Iancovici-Kidon M, Yassky D, Raz M. (2007). Increased Th1 and Th2 type cytokine production in patients with active tuberculosis. Isr Med Assoc J 9:479–483.
   PubMed Web of Science ®Google Scholar
• Hasan Z, Cliff JM, Dockrell HM, Jamil B, Irfan M, Ashraf M, Hussain R. (2009a). CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis. PLoS ONE 4:e8459.
   Google Scholar
• Hasan Z, Jamil B, Ashraf M, Islam M, Dojki M, Irfan M, Hussain R. (2009b). Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis. Clin Vaccine Immunol 16:991–998.
   Google Scholar
• He XY, Xiao L, Chen HB, Hao J, Li J, Wang YJ, He K, Gao Y, Shi BY. (2010). T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients. Eur J Clin Microbiol Infect Dis 29:643–650.
   PubMed Web of Science ®Google Scholar
• Hussain R, Kaleem A, Shahid F, Dojki M, Jamil B, Mehmood H, Dawood G, Dockrell HM. (2002). Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. J Immunol Methods 264:95–108.
   PubMed Web of Science ®Google Scholar
• Immanuel C, Swamy R, Kannapiran M, Vijayalakshmi S, Sundaram V, Jagannath K, Paramasivan CN. (1997). Neopterin as a marker for cell-mediated immunity in patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 1:175–180.
   PubMedGoogle Scholar
• Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, Mollenkopf HJ, Ziegler A, Kaufmann SH. (2007). Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med 85:613–621.
   PubMed Web of Science ®Google Scholar
• Jacobsen M, Repsilber D, Kleinsteuber K, Gutschmidt A, Schommer-Leitner S, Black G, Walzl G, Kaufmann SH. (2010). Suppressor of cytokine signaling (SOCS)-3 is affected in T cells from TB patients. Clin Microbiol Infect: DOI: 10.1111/j.469-0691.2010.03326.x.
   Google Scholar
• Kaido T. (2007). Characteristics and quality of randomized controlled trials in the treatment of hepatocellular carcinoma. Dig Dis Sci 52:1108–1113.
   Google Scholar
• Kaido T, Uemoto S. (2008). Quality assessment of randomized controlled trials involving liver surgery. Hepatogastroenterology 55:1678–1680.
   Google Scholar
• Kaufmann SH. (2010). Novel tuberculosis vaccination strategies based on understanding the immune response. J Intern Med 267:337–353.
   PubMed Web of Science ®Google Scholar
• Kaufmann SH, McMichael AJ. (2005). Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med 11:S33–S44.
   PubMed Web of Science ®Google Scholar
• Lange C, Pai M, Drobniewski F, Migliori GB. (2009). Interferon-gamma release assays for the diagnosis of active tuberculosis: sensible or silly? Eur Respir J 33:1250–1253.
   Google Scholar
• Lui G, Lee N, Cheung SW, Lam JS, Wong BC, Choi KW, Wong KT, Wong RY, Cockram CS, Hui DS, Chan RC. (2011). Interferon gamma release assay for differentiating tuberculosis among pneumonia cases in acute healthcare setting. J Infect 62:440–447.
   Google Scholar
• Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, Black G, Walzl G, Kaufmann SH. (2011). Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun 12:15–22.
   PubMed Web of Science ®Google Scholar
• Matsuyama W, Kubota R, Hashiguchi T, Momi H, Kawabata M, Nakagawa M, Arimura K, Osame M. (2002). Purified protein derivative of tuberculin upregulates the expression of vascular endothelial growth factor in T lymphocytes in vitro. Immunology 106:96–101.
   PubMed Web of Science ®Google Scholar
• Mattos AM, Almeida Cde S, Franken KL, Alves CC, Abramo C, de Souza MA, L’Hotellier M, Alves MJ, Ferreira AP, Oliveira SC, Ottenhoff TH, Teixeira HC. (2010). Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy. Int Immunol 22:775–782.
   PubMed Web of Science ®Google Scholar
• Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K; IGRA Expert Committee; Centers for Disease Control and Prevention (CDC). (2010). Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 59:1–25.
   PubMedGoogle Scholar
• Mistry R, Cliff JM, Clayton CL, Beyers N, Mohamed YS, Wilson PA, Dockrell HM, Wallace DM, van Helden PD, Duncan K, Lukey PT. (2007). Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis. J Infect Dis 195:357–365.
   Google Scholar
• Nagabhushanam V, Solache A, Ting LM, Escaron CJ, Zhang JY, Ernst JD. (2003). Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma. J Immunol 171:4750–4757.
   PubMed Web of Science ®Google Scholar
• Nemeth J, Winkler HM, Karlhofer F, Selenko-Gebauer N, Graninger W, Winkler S. (2010). T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis. Eur Cytokine Netw 21:34–39.
   PubMed Web of Science ®Google Scholar
• Othieno C, Hirsch CS, Hamilton BD, Wilkinson K, Ellner JJ, Toossi Z. (1999). Interaction of Mycobacterium tuberculosis-induced transforming growth factor beta1 and interleukin-10. Infect Immun 67:5730–5735.
   Google Scholar
• Parida SK, Kaufmann SH. (2010). The quest for biomarkers in tuberculosis. Drug Discov Today 15:148–157.
   PubMed Web of Science ®Google Scholar
• Petrucci R, Abu Amer N, Gurgel RQ, Sherchand JB, Doria L, Lama C, Ravn P, Ruhwald M, Yassin M, Harper G, Cuevas LE. (2008). Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection. Pediatr Infect Dis J 27:1073–1077.
   PubMedGoogle Scholar
• Pokkali S, Das SD. (2009). Augmented chemokine levels and chemokine receptor expression on immune cells during pulmonary tuberculosis. Hum Immunol 70:110–115.
   PubMed Web of Science ®Google Scholar
• Roberts T, Beyers N, Aguirre A, Walzl G. (2007). Immunosuppression during active tuberculosis is characterized by decreased interferon- gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor- beta, and interleukin-4 mRNA levels. J Infect Dis 195:870–878.
   PubMed Web of Science ®Google Scholar
• Ruhwald M, Bjerregaard-Andersen M, Rabna P, Eugen-Olsen J, Ravn P. (2009). IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay. BMC Res Notes 2:19.
   PubMedGoogle Scholar
• Ruhwald M, Bjerregaard-Andersen M, Rabna P, Kofoed K, Eugen-Olsen J, Ravn P. (2007). CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect 9:806–812.
   PubMed Web of Science ®Google Scholar
• Ruhwald M, Bodmer T, Maier C, Jepsen M, Haaland MB, Eugen-Olsen J, Ravn P; TBNET. (2008). Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J 32:1607–1615.
   PubMed Web of Science ®Google Scholar
• Sai Priya VH, Anuradha B, Latha Gaddam S, Hasnain SE, Murthy KJ, Valluri VL. (2009). In vitro levels of interleukin 10 (IL-10) and IL-12 in response to a recombinant 32-kilodalton antigen of Mycobacterium bovis BCG after treatment for tuberculosis. Clin Vaccine Immunol 16:111–115.
   Google Scholar
• Sargentini V, Mariotti S, Carrara S, Gagliardi MC, Teloni R, Goletti D, Nisini R. (2009). Cytometric detection of antigen-specific IFN-gamma/IL-2 secreting cells in the diagnosis of tuberculosis. BMC Infect Dis 9:99.
   PubMedGoogle Scholar
• Seah GT, Scott GM, Rook GA. (2000). Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 181:385–389.
   PubMed Web of Science ®Google Scholar
• Stern JN, Keskin DB, Romero V, Zuniga J, Encinales L, Li C, Awad C, Yunis EJ. (2009). Molecular signatures distinguishing active from latent tuberculosis in peripheral blood mononuclear cells, after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD) or Candida: a preliminary report. Immunol Res 45:1–12.
   PubMed Web of Science ®Google Scholar
• Su WL, Perng WC, Huang CH, Yang CY, Wu CP, Chang FY, Chen JH. (2010). Identification of cytokines in whole blood for differential diagnosis of tuberculosis versus pneumonia. Clin Vaccine Immunol 17:771–777.
   Google Scholar
• Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MO. (2009). Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur J Immunol 39:723–729.
   PubMed Web of Science ®Google Scholar
• Sutherland JS, de Jong BC, Jeffries DJ, Adetifa IM, Ota MO. (2010). Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort. PLoS ONE 5:e12365.
   PubMed Web of Science ®Google Scholar
• Talreja J, Bhatnagar A, Jindal SK, Ganguly NK. (2003). Influence of Mycobacterium tuberculosis on differential activation of helper T-cells. Clin Exp Immunol 131:292–298.
   Google Scholar
• Thuong NT, Dunstan SJ, Chau TT, Thorsson V, Simmons CP, Quyen NT, Thwaites GE, Thi Ngoc Lan N, Hibberd M, Teo YY, Seielstad M, Aderem A, Farrar JJ, Hawn TR. (2008). Identification of tuberculosis susceptibility genes with human macrophage gene expression profiles. PLoS Pathog 4:e1000229.
   PubMedGoogle Scholar
• Turgut T, Akbulut H, Deveci F, Kacar C, Muz MH. (2006). Serum interleukin-2 and neopterin levels as useful markers for treatment of active pulmonary tuberculosis. Tohoku J Exp Med 209:321–328.
   PubMed Web of Science ®Google Scholar
• Verbon A, Juffermans N, Van Deventer SJ, Speelman P, Van Deutekom H, Van Der Poll T. (1999). Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol 115:110–113.
   PubMed Web of Science ®Google Scholar
• Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, Zumla A. (2010). Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 375:1920–1937.
   PubMed Web of Science ®Google Scholar
• Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A. (2011). Immunological biomarkers of tuberculosis. Nat Rev Immunol 11:343–354.
   PubMed Web of Science ®Google Scholar
• Wassie L, Demissie A, Aseffa A, Abebe M, Yamuah L, Tilahun H, Petros B, Rook G, Zumla A, Andersen P, Doherty TM; VACSEL Study Group. (2008). Ex vivo cytokine mRNA levels correlate with changing clinical status of ethiopian TB patients and their contacts over time. PLoS ONE 3:e1522.
   Google Scholar
• Whittaker E, Gordon A, Kampmann B. (2008). Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma? PLoS ONE 3:e3901.
   PubMed Web of Science ®Google Scholar
• WHO. (2009). Global tuberculosis control. A short update to the 2009 report, Geneva.
   Google Scholar
• Wu B, Huang C, Kato-Maeda M, Hopewell PC, Daley CL, Krensky AM, Clayberger C. (2007). Messenger RNA expression of IL-8, FOXP3, and IL-12beta differentiates latent tuberculosis infection from disease. J Immunol 178:3688–3694.
   PubMedGoogle Scholar
• Wu B, Huang C, Kato-Maeda M, Hopewell PC, Daley CL, Krensky AM, Clayberger C. (2008). IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis. Clin Immunol 126:202–210.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Broser M, Rom WN. (1994). Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-kappa B. Proc Natl Acad Sci USA 91:2225–2229.
   PubMedGoogle Scholar